Skip to main content
. 2016 May 11;101(9):3450–3458. doi: 10.1210/jc.2016-1257

Table 3.

Agreement of Each IGF-I Assay Method Against Each of the Others, Expressed as Weighted Kappa and Percentages of Observed Agreement

LIAISON XL iSYS IMMULITE 2000 Mediagnost ELISA Mediagnost RIA IGFI- RIACT
LIAISON XL 0.49 0.50 0.47 0.38 0.48
94.86% 94.83% 94.95% 94.05% 95.22%
iSYS 0.49 0.64 0.61 0.70 0.64
94.86% 96.08% 96.11% 97.00% 96.46%
IMMULITE 2000 0.50 0.64 0.61 0.58 0.64
94.83% 96.08% 95.95% 95.73% 96.32%
Mediagnost ELISA 0.47 0.61 0.61 0.59 0.53
94.95% 96.11% 95.95% 96.00% 95.66%
Mediagnost 0.38 0.70 0.58 0.59 0.48
RIA 94.05% 97.00% 95.73% 96.00% 95.22%
IGFI- RIACT 0.48 0.64 0.64 0.53 0.48
95.22% 96.46% 96.32% 95.66% 95.22%